These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 19251054

  • 1. Modification of androgen receptor function by IGF-1 signaling implications in the mechanism of refractory prostate carcinoma.
    Yanase T, Fan W.
    Vitam Horm; 2009; 80():649-66. PubMed ID: 19251054
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.
    Fan W, Yanase T, Morinaga H, Okabe T, Nomura M, Daitoku H, Fukamizu A, Kato S, Takayanagi R, Nawata H.
    J Biol Chem; 2007 Mar 09; 282(10):7329-38. PubMed ID: 17202144
    [Abstract] [Full Text] [Related]

  • 3. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G, Mineo R, Frasca F, Roberts CT, Marcelli M, Vigneri R, Belfiore A.
    Cancer Res; 2005 Mar 01; 65(5):1849-57. PubMed ID: 15753383
    [Abstract] [Full Text] [Related]

  • 4. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H.
    Cancer Res; 1994 Oct 15; 54(20):5474-8. PubMed ID: 7522959
    [Abstract] [Full Text] [Related]

  • 5. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR.
    J Cell Biochem; 2006 Oct 01; 99(2):392-401. PubMed ID: 16639715
    [Abstract] [Full Text] [Related]

  • 6. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
    Liu X, Choi RY, Jawad SM, Arnold JT.
    Prostate; 2011 May 15; 71(7):766-77. PubMed ID: 21031436
    [Abstract] [Full Text] [Related]

  • 7. GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4.
    Huo X, Liu S, Shao T, Hua H, Kong Q, Wang J, Luo T, Jiang Y.
    J Biol Chem; 2014 Sep 05; 289(36):24759-70. PubMed ID: 25053419
    [Abstract] [Full Text] [Related]

  • 8. Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor.
    Verras M, Sun Z.
    Mol Endocrinol; 2005 Feb 05; 19(2):391-8. PubMed ID: 15514031
    [Abstract] [Full Text] [Related]

  • 9. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.
    Yan Y, Huang H.
    Adv Exp Med Biol; 2019 Feb 05; 1210():319-331. PubMed ID: 31900915
    [Abstract] [Full Text] [Related]

  • 10. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
    Takayama K, Horie-Inoue K, Ikeda K, Urano T, Murakami K, Hayashizaki Y, Ouchi Y, Inoue S.
    Biochem Biophys Res Commun; 2008 Sep 19; 374(2):388-93. PubMed ID: 18640093
    [Abstract] [Full Text] [Related]

  • 11. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation.
    Lynch RL, Konicek BW, McNulty AM, Hanna KR, Lewis JE, Neubauer BL, Graff JR.
    Mol Cancer Res; 2005 Mar 19; 3(3):163-9. PubMed ID: 15798096
    [Abstract] [Full Text] [Related]

  • 12. Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines.
    Orio F, Térouanne B, Georget V, Lumbroso S, Avances C, Siatka C, Sultan C.
    Mol Cell Endocrinol; 2002 Dec 30; 198(1-2):105-14. PubMed ID: 12573820
    [Abstract] [Full Text] [Related]

  • 13. Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer.
    Huang EC, Chen G, Baek SJ, McEntee MF, Collier JJ, Minkin S, Biggerstaff J, Whelan J.
    Nutr Cancer; 2011 Nov 30; 63(8):1287-96. PubMed ID: 21958043
    [Abstract] [Full Text] [Related]

  • 14. A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.
    Liu P, Li S, Gan L, Kao TP, Huang H.
    Cancer Res; 2008 Dec 15; 68(24):10290-9. PubMed ID: 19074897
    [Abstract] [Full Text] [Related]

  • 15. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
    Plymate SR, Tennant MK, Culp SH, Woodke L, Marcelli M, Colman I, Nelson PS, Carroll JM, Roberts CT, Ware JL.
    Prostate; 2004 Nov 01; 61(3):276-90. PubMed ID: 15368471
    [Abstract] [Full Text] [Related]

  • 16. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R.
    Oncogene; 2006 Mar 30; 25(14):2011-21. PubMed ID: 16434977
    [Abstract] [Full Text] [Related]

  • 17. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
    Reddy GP, Barrack ER, Dou QP, Menon M, Pelley R, Sarkar FH, Sheng S.
    J Cell Biochem; 2006 Aug 15; 98(6):1408-23. PubMed ID: 16619263
    [Abstract] [Full Text] [Related]

  • 18. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
    Terry S, Yang X, Chen MW, Vacherot F, Buttyan R.
    J Cell Biochem; 2006 Oct 01; 99(2):402-10. PubMed ID: 16741972
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway.
    Li J, Wang E, Rinaldo F, Datta K.
    Oncogene; 2005 Aug 18; 24(35):5510-20. PubMed ID: 15897888
    [Abstract] [Full Text] [Related]

  • 20. Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates androgen receptor transactivation in prostate cancer cells.
    Lee HJ, Hwang M, Chattopadhyay S, Choi HS, Lee K.
    Biochem Biophys Res Commun; 2008 Mar 07; 367(2):481-6. PubMed ID: 18178153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.